| Name | Title | Contact Details |
|---|
The M+A name represents two powerful brands – Mountville and Andersen – with nearly a century of combined experience developing and manufacturing mats designed to make environments safer, cleaner, and more comfortable. In 1963, the late Emmett Hart, with his wife Nancy by his side, established Mountville Mills. A little over a decade later, in 1974, the late Walter Andersen established The Andersen Company. Throughout the years, the companies drove innovations in their respective markets; Mountville in the textile rental market, and Andersen in the janitorial/sanitary supply markets. Outstanding quality and customer service paved the way for future generations of Harts and Andersens to expand the business. In 1999, these flagship brands joined forces to become the largest mat manufacturer in the world, and in 2018 we made the union official with a name change to M+A Matting. For decades, weve been a symbol of quality and customer service. Were the driving force in the mat industry, developing the next generation of mats designed to provide superior safety, cleanliness, and comfort to workers and customers across the world. Our diverse product mix is a direct reflection of our diverse customers and end users who span virtually every industry – healthcare, hospitality, food service, retail, education, industrial, and commercial.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
People always ask, what does strategic communications mean? For us, it means finding interesting, smart, and inventive ways to get information to the right people. It means streamlining programs that are cumbersome, messy, and confusing and making them easy to use. It means identifying dated layout and design and creating content that is stunning and engaging. Based in Natick, MA, Strategic Communications, Inc. (StratComm) has served the marketing, communications, training, and project management needs of nationwide Fortune 500 companies, many federal agencies, and all branches of the Armed Forces for over 45 years. Our team works with a variety of clients and delivers an array of services. We create high-quality publications, both print and electronic, and training platforms for leading corporations and organizations such as IBM, VMware, the United States Navy and Air Force, the U.S. Department of State, Veterans Affairs, the U.S. Treasury, and many other important agencies and organizations. We also manage large programs for the federal government utilizing emerging technologies. Two examples are online training and testing programs for U.S. Embassies worldwide and program management for the Social Security Administration. Many high profile clients contract with StratComm to update the design and content of their websites, brochures, annual reports, and web apps. Our team is constantly seeking newer technologies and developing efficiencies to better serve our clients. Within our headquarters, we house a core team of dedicated professionals who administer our programs. Together, we manage varied projects and communications challenges for both large and small clients. Strategically, of course.
AmeriVet Veterinary Partners is a company dedicated to supporting veterinary practices across the United States. Founded in 2016 and based in San Antonio, Texas, AmeriVet provides a range of business solutions that allow veterinary clinics to focus on animal care while benefiting from the companys resources and expertise. The services offered by AmeriVet include operational support, marketing strategies, professional training programs, human resources assistance, and financial management tools. These services are designed to enhance the efficiency and profitability of veterinary practices. AmeriVet operates on a partnership model, offering joint venture and full acquisition options that enable practice owners to maintain a stake in their business while accessing comprehensive support. With reported revenue of $205.5 million and significant funding, AmeriVet is recognized as a leading partner for veterinary clinics nationwide. The company has also been acknowledged as one of the top places to work in 2023, reflecting its commitment to a positive work environment for employees.